Tatva Chintan Pharma Chem Limited (TATVA) Stock - Complete Technical Analysis - Aug 30, 2024

Tatva Chintan Pharma Chem (TATVA) Stock Analysis: Key Support

Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in stocks involves risks, and it's essential to conduct thorough research or consult with a financial advisor before making investment decisions. Tatva Chintan Pharma Chem Limited, trading at 960, is exhibiting a complex technical picture. The stock is significantly below its 52-week high of 1752.95, suggesting a notable downtrend with current price just 1.49% above its 52-week low of 945.8. Key technical indicators are mixed, with the MACD showing a negative value, indicating bearish momentum. The RSI, below 40, points to potential oversold conditions, while the Stochastic %K is low, suggesting further downside risk. The ADX is moderate, reflecting a trend but not a strong one, and the Awesome Oscillator is also negative, supporting the bearish sentiment. The stock's moving averages show a clear downtrend, with shorter-term EMAs and SMAs below longer-term averages. Notably, the price is below significant moving averages like the 50-day and 200-day, which might act as resistance levels. Support levels are suggested by the Classic Pivot S1 at 922.62, with further support potentially around the Camarilla S1 at 979.2 and the Fibonacci S1 at 979.17. Resistance could be seen at Classic Pivot P at 1061.28 and the Woodie R1 at 1115.47. Given the current trading environment and technical indicators, traders should be cautious and watch for potential reversal signals before making trading decisions.